HLA-E表达构成了造血干细胞移植后急性淋巴细胞白血病疾病监测的一个新的决定因素。 - Suppr

HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantation.

作者信息

Reusing Sarah B, Manser Angela R, Groeneveld-Krentz Stefanie, Rebmann Vera, Horn Peter A, Meisel Roland, Karawajew Leonid, Borkhardt Arndt, Uhrberg Markus, Babor Florian

机构信息

Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University, Düsseldorf, Germany.

Department of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.

出版信息

Bone Marrow Transplant. 2021 Jul;56(7):1723-1727. doi: 10.1038/s41409-021-01231-y. Epub 2021 Mar 3.

DOI:10.1038/s41409-021-01231-y

PMID:33658648

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8263342/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac61/8263342/744f976a0743/41409_2021_1231_Fig1_HTML.jpg

相似文献

HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantation.HLA-E表达构成了造血干细胞移植后急性淋巴细胞白血病疾病监测的一个新的决定因素。

Bone Marrow Transplant. 2021 Jul;56(7):1723-1727. doi: 10.1038/s41409-021-01231-y. Epub 2021 Mar 3.

The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation.HLA-E基因多态性对HLA-E配型相合的异基因造血干细胞移植后移植物抗宿主病的影响

Iran J Allergy Asthma Immunol. 2012 Mar;11(1):15-21.

Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.多中心分析表明，在 HLA 匹配的相关和无关造血干细胞移植后，次要组织相容性抗原对移植物抗宿主病和移植物抗肿瘤效应具有显著的临床影响。

Biol Blood Marrow Transplant. 2013 Aug;19(8):1244-53. doi: 10.1016/j.bbmt.2013.06.001. Epub 2013 Jun 10.

HLA matching for hematopoietic stem-cell transplants.造血干细胞移植的人类白细胞抗原配型

N Engl J Med. 2002 Apr 18;346(16):1251-2; author reply 1251-2. doi: 10.1056/NEJM200204183461616.

Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia.供者 T 细胞在 HLA Ⅱ类障碍中给药可介导抗肿瘤免疫，而在急性白血病的 NOD/scid 小鼠模型中无广泛的脱靶毒性。

Biol Blood Marrow Transplant. 2013 Jun;19(6):867-75. doi: 10.1016/j.bbmt.2013.03.003. Epub 2013 Mar 13.

Selection of unrelated donors for hematopoietic cell transplantation.造血细胞移植无关供者的选择

Curr Hematol Rep. 2005 Jul;4(4):270-5.

Transplantation of hematopoietic stem cells (HSC).造血干细胞移植

Br Med Bull. 1987 Jan;43(1):203-16. doi: 10.1093/oxfordjournals.bmb.a072171.

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.人类白细胞抗原I类和II类高分辨率配型对无关供者骨髓移植结局的影响：人类白细胞抗原C位点错配与移植结局的严重不良影响相关。

Blood. 2004 Oct 1;104(7):1923-30. doi: 10.1182/blood-2004-03-0803. Epub 2004 Jun 10.

Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.HLA I类高分辨率错配对接受无关供者造血干细胞移植患者慢性移植物抗宿主病及生存的影响。

Bone Marrow Transplant. 2005 Jan;35(1):57-62. doi: 10.1038/sj.bmt.1704741.

Identification of MHC II-restricted minor histocompatibility antigens after HLA-identical stem-cell transplantation.HLA 一致造血干细胞移植后 MHC II 限制性次要组织相容性抗原的鉴定。

Transplantation. 2010 Nov 15;90(9):1030-5. doi: 10.1097/TP.0b013e3181f5470c.

引用本文的文献

Polygenic polymorphism is associated with NKG2A repertoire and influences lymphocyte phenotype and function.多基因多态性与 NKG2A 库有关，并影响淋巴细胞表型和功能。

Blood Adv. 2024 Oct 22;8(20):5382-5399. doi: 10.1182/bloodadvances.2024013508.

Non-classical HLA-E restricted CMV 15-mer peptides are recognized by adaptive NK cells and induce memory responses.非经典 HLA-E 限制性 CMV 15 肽被适应性 NK 细胞识别并诱导记忆应答。

Front Immunol. 2023 Sep 21;14:1230718. doi: 10.3389/fimmu.2023.1230718. eCollection 2023.

Detailed phenotypic and functional characterization of CMV-associated adaptive NK cells in rhesus macaques.详细的表型和功能表征猕猴巨细胞病毒相关适应性 NK 细胞。

Front Immunol. 2022 Nov 25;13:1028788. doi: 10.3389/fimmu.2022.1028788. eCollection 2022.

本文引用的文献

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.抗 NKG2A mAb 是一种检查点抑制剂，通过释放 T 细胞和 NK 细胞来促进抗肿瘤免疫。

Cell. 2018 Dec 13;175(7):1731-1743.e13. doi: 10.1016/j.cell.2018.10.014. Epub 2018 Nov 29.

Minimal residual disease (MRD) detection using rearrangement of immunoglobulin/T cell receptor genes in adult patients with acute lymphoblastic leukemia (ALL).利用免疫球蛋白/T细胞受体基因重排检测成年急性淋巴细胞白血病（ALL）患者的微小残留病（MRD）

Ann Hematol. 2018 Apr;97(4):585-595. doi: 10.1007/s00277-018-3230-z. Epub 2018 Feb 1.

Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia.治疗性CD94/NKG2A阻断可改善慢性淋巴细胞白血病中的自然杀伤细胞功能障碍。

Oncoimmunology. 2016 Sep 9;5(10):e1226720. doi: 10.1080/2162402X.2016.1226720. eCollection 2016.

Selective downregulation of HLA-C and HLA-E in childhood acute lymphoblastic leukaemia.儿童急性淋巴细胞白血病中HLA-C和HLA-E的选择性下调

Br J Haematol. 2016 Aug;174(3):477-80. doi: 10.1111/bjh.13777. Epub 2015 Nov 3.

Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.采用八色流式细胞术对复发性儿童急性淋巴细胞白血病进行微小残留病分析。

Haematologica. 2015 Jul;100(7):935-44. doi: 10.3324/haematol.2014.116707. Epub 2015 May 22.

KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapse.KIR 配体 C2 与儿童 ALL 的易感性增加相关，并赋予晚期复发的高风险。

Blood. 2014 Oct 2;124(14):2248-51. doi: 10.1182/blood-2014-05-572065. Epub 2014 Aug 27.

CD44 and CD27 delineate B-precursor stages with different recombination status and with an uneven distribution in nonmalignant and malignant hematopoiesis.CD44和CD27可区分具有不同重组状态且在非恶性和恶性造血中分布不均的B前体细胞阶段。

Tissue Antigens. 2008 Jan;71(1):57-66. doi: 10.1111/j.1399-0039.2007.00968.x. Epub 2007 Nov 13.

Intensity of HLA class I expression and KIR-mismatch determine NK-cell mediated lysis of leukaemic blasts from children with acute lymphatic leukaemia.HLA I类分子表达强度和KIR错配决定自然杀伤细胞对急性淋巴细胞白血病患儿白血病原始细胞的杀伤作用。

Br J Haematol. 2007 Jul;138(1):97-100. doi: 10.1111/j.1365-2141.2007.06631.x.

Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112).自然杀伤细胞介导的新鲜分离的髓系或淋巴细胞白血病细胞裂解中受体-配体相互作用的分析：脊髓灰质炎病毒受体（CD155）和Nectin-2（CD112）参与的证据

Blood. 2005 Mar 1;105(5):2066-73. doi: 10.1182/blood-2004-09-3548. Epub 2004 Nov 9.

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.供体自然杀伤细胞同种异体反应性在不匹配造血移植中的有效性。

Science. 2002 Mar 15;295(5562):2097-100. doi: 10.1126/science.1068440.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantation.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献